Ind-Ra pegs Pharma FY27 revenue growth at 10% as domestic demand, CDMOs cushion US decline – ETPharma.com
Ind-Ra pegs Pharma FY27 revenue growth at 10% as domestic demand, CDMOs cushion US decline ETPharma.com
Read the full story at source →
Ind-Ra pegs Pharma FY27 revenue growth at 10% as domestic demand, CDMOs cushion US decline ETPharma.com
Read the full story at source →
Post Comment